S. Shoham

Clinical Infectious Diseases · 2011–2022

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from S. Shoham's perspective

Ordered by how strongly the researchers S. Shoham trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
  2. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)
  4. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)
  6. Clinical Characteristics of Coronavirus Disease 2019 in China (Journal of Emergency Medicine)
  7. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (Proceedings of the National Academy of Sciences of the United States of America)
  8. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (Journal of Infectious Diseases)
  9. GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
  10. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. (Journal of the American Medical Association (JAMA))

Their papers